Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
She was most recently a correspondent at Kaiser Health News, where she covered drug prices and specialized in data reporting for its enterprise team. She's reported on how tainted drugs can reach consumers, how companies take advantage of rare disease drug rules and how FDA-approved generics often don't make it to market. She's also tracked pharmaceutical dollars to patient advocacy groups and members of Congress. Her work has won the National Press Club's Joan M. Friedenberg Online Journalism Award, the National Institute for Health Care Management's Digital Media Award and a health reporting award from the Society for Advancing Business Editing and Writing.
Lupkin graduated from Boston University. She's also worked for ABC News, VICE News, MedPage Today and The Bay Citizen. Her internship and part-time work includes stints at ProPublica, The Boston Globe, The Boston Herald, The New England Center for Investigative Reporting and WCVB.
-
A tornado that tore through a Pfizer factory in North Carolina could exacerbate drug shortages. Records obtained by NPR show the plant made dozens of products, including painkillers and anesthetics.
-
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign.
-
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now some copycats could end Humira's reign.
-
The Food and Drug Administration has approved the first over-the-counter birth control pill. The daily oral contraceptive, called Opill, will be available without a prescription.
-
Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year. -
Here's what really went down when the FDA originally approved mifepristone in 2000. -
Strep throat is more prevalent this year, and amoxicillin manufacturers didn't make enough of the antibiotic to go around. -
There's a nationwide shortage of the antibiotic amoxicillin. It is making it harder for doctors to treat strep throat.
-
Future access to the abortion drug mifepristone is called into question following competing rulings from federal judges in Texas and Washington State.
-
The FDA approved Narcan for sale without a prescription. The opioid overdose reversal drug would be available at pharmacies and convenience stores nationally, increasing access as opioid deaths climb.
